BIT:FF - Euronext Milan - IT0005215329 - Common Stock - Currency: EUR
BIT:FF (3/3/2025, 7:00:00 PM)
6.88
+0.12 (+1.78%)
The current stock price of FF.MI is 6.88 EUR. In the past month the price decreased by -14.43%. In the past year, price decreased by -15.17%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TN8.DE | THERMO FISHER SCIENTIFIC INC | 24.07 | 182.78B | ||
DAP.DE | DANAHER CORP | 28.32 | 139.67B | ||
DIM.PA | SARTORIUS STEDIM BIOTECH | 55.17 | 18.79B | ||
56S1.DE | SARTORIUS STEDIM BIOTECH | 55.17 | 18.79B | ||
SRT3.DE | SARTORIUS AG-VORZUG | 46.36 | 17.15B | ||
SRT.DE | SARTORIUS AG | 37.17 | 13.75B | ||
ILU.DE | ILLUMINA INC | 34.19 | 12.24B | ||
ESF0.DE | EUROFINS SCIENTIFIC | 28.63 | 9.95B | ||
ERF.PA | EUROFINS SCIENTIFIC | 28.53 | 9.91B | ||
QIA.DE | QIAGEN N.V. | 18.07 | 7.89B | ||
1SXP.DE | SCHOTT PHARMA AG& CO KGAA | 25.09 | 3.74B | ||
GXI.DE | GERRESHEIMER AG | 25.2 | 2.77B |
Fine Foods & Pharmaceuticals N.T.M. The company is headquartered in Verdellino, Bergamo and currently employs 753 full-time employees. The company went IPO on 2016-10-19. The company is specialized in the manufacturing of pharmaceutical products for third parties. The firm manages three segments: Pharmaceuticals, Nutraceuticals and Medical Devices. The Pharmaceuticals segment includes powders and granules, tablets, coated tablets and hard gelatin capsules, packaged in sachets, blisters and bottles. The Nutraceuticals segment includes soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, coated tablets and hard gelatin capsules packaged in bags, sachets, sticks, jars, tablet bottles, blisters and strips. The Medical Devices segment includes tablets, capsules, powders, granules and cover the areas for gastrointestinal, oral and throat treatment and the weight management. Medical Devices marked CE (European Conformity) are available for licensing.
FINE FOODS & PHARMACEUTICALS
Via Berlino, 39, Zingonia
Verdellino BERGAMO IT
Employees: 780
Company Website: https://www.finefoods.it
Investor Relations: http://www.finefoods.it/en/financial-reports/
Phone: 390354821382
The current stock price of FF.MI is 6.88 EUR. The price increased by 1.78% in the last trading session.
The exchange symbol of FINE FOODS & PHARMACEUTICALS is FF and it is listed on the Euronext Milan exchange.
FF.MI stock is listed on the Euronext Milan exchange.
10 analysts have analysed FF.MI and the average price target is 12.24 EUR. This implies a price increase of 77.91% is expected in the next year compared to the current price of 6.88. Check the FINE FOODS & PHARMACEUTICALS stock analysts ratings, price target forecast and up-and down grades for more detailed information.
FINE FOODS & PHARMACEUTICALS (FF.MI) has a market capitalization of 151.77M EUR. This makes FF.MI a Micro Cap stock.
FINE FOODS & PHARMACEUTICALS (FF.MI) currently has 780 employees.
FINE FOODS & PHARMACEUTICALS (FF.MI) has a support level at 6.87 and a resistance level at 6.89. Check the full technical report for a detailed analysis of FF.MI support and resistance levels.
The Revenue of FINE FOODS & PHARMACEUTICALS (FF.MI) is expected to decline by -1.25% in the next year. Check the estimates tab for more information on the FF.MI EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
FINE FOODS & PHARMACEUTICALS (FF.MI) has a dividend yield of 1.75%. The yearly dividend amount is currently 0.1. Check the full fundamental report for a detailed analysis of FF.MI dividend history, reliability and sustainability.
FINE FOODS & PHARMACEUTICALS (FF.MI) will report earnings on 2025-03-27, after the market close.
The PE ratio for FINE FOODS & PHARMACEUTICALS (FF.MI) is 19.11. This is based on the reported non-GAAP earnings per share of 0.36 and the current share price of 6.88 EUR. Check the full fundamental report for a full analysis of the valuation metrics for FF.MI.
ChartMill assigns a fundamental rating of 5 / 10 to FF.MI. FF.MI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months FF.MI reported a non-GAAP Earnings per Share(EPS) of 0.36. The EPS increased by 457.94% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 2.06% | ||
ROA | 3.26% | ||
ROE | 5.8% | ||
Debt/Equity | 0.28 |
ChartMill assigns a Buy % Consensus number of 86% to FF.MI. The Buy consensus is the average rating of analysts ratings from 10 analysts.
For the next year, analysts expect an EPS growth of 95.47% and a revenue growth -1.25% for FF.MI